FRA
ABBV icon

Front Row Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.79M Sell
25,815
-263
-1% -$48.8K 1.67% 10
2025
Q1
$5.46M Sell
26,078
-878
-3% -$184K 2.1% 8
2024
Q4
$4.79M Sell
26,956
-116
-0.4% -$20.6K 1.65% 9
2024
Q3
$5.35M Sell
27,072
-274
-1% -$54.1K 1.91% 8
2024
Q2
$4.69M Buy
27,346
+265
+1% +$45.5K 1.63% 10
2024
Q1
$4.93M Buy
27,081
+269
+1% +$49K 1.83% 10
2023
Q4
$4.16M Sell
26,812
-426
-2% -$66K 1.91% 9
2023
Q3
$4.06M Sell
27,238
-507
-2% -$75.6K 1.87% 7
2023
Q2
$3.74M Buy
27,745
+39
+0.1% +$5.25K 1.66% 8
2023
Q1
$4.42M Buy
27,706
+318
+1% +$50.7K 2.12% 6
2022
Q4
$4.43M Sell
27,388
-1,099
-4% -$178K 2.29% 4
2022
Q3
$3.82M Sell
28,487
-83
-0.3% -$11.1K 1.98% 6
2022
Q2
$4.38M Sell
28,570
-185
-0.6% -$28.3K 2.15% 5
2022
Q1
$4.66M Buy
28,755
+40
+0.1% +$6.49K 1.88% 6
2021
Q4
$3.89M Buy
28,715
+857
+3% +$116K 1.45% 12
2021
Q3
$3.01M Sell
27,858
-43
-0.2% -$4.64K 1.27% 16
2021
Q2
$3.29M Buy
27,901
+385
+1% +$45.4K 1.35% 13
2021
Q1
$2.98M Buy
27,516
+1,024
+4% +$111K 1.44% 11
2020
Q4
$2.84M Sell
26,492
-323
-1% -$34.6K 1.45% 11
2020
Q3
$2.81M Sell
26,815
-668
-2% -$70.1K 1.49% 8
2020
Q2
$2.7M Sell
27,483
-415
-1% -$40.7K 1.67% 7
2020
Q1
$2.29M Buy
27,898
+1,725
+7% +$142K 1.55% 10
2019
Q4
$2.32M Sell
26,173
-1,261
-5% -$112K 1.51% 9
2019
Q3
$2.08M Sell
27,434
-431
-2% -$32.6K 1.48% 10
2019
Q2
$2.03M Buy
27,865
+267
+1% +$19.4K 1.48% 11
2019
Q1
$2.22M Buy
27,598
+590
+2% +$47.5K 1.73% 8
2018
Q4
$2.49M Sell
27,008
-587
-2% -$54.1K 2.17% 4
2018
Q3
$2.19K Sell
27,595
-245
-0.9% -$19 1.54% 9
2018
Q2
$2.59K Buy
27,840
+119
+0.4% +$11 1.66% 7
2018
Q1
$2.62M Sell
27,721
-82
-0.3% -$7.76K 1.84% 5
2017
Q4
$2.69M Buy
+27,803
New +$2.69M 2.14% 4